Implementation Framework for the ISHLT Statement on Transplant Ethics
Published 23 July 2026
The Ethics Committee has developed a principles-based ISHLT Statement on Transplant Ethics that articulates the Society’s core ethical values while intentionally avoiding case-specific rules or operational guidance. A separate implementation framework determined by the Board of Directors guides the application of those principles to ISHLT programs, beginning with scientific abstracts submitted for the 2027 Annual Meeting.
The purpose of this implementation framework is not to certify the ethical practices of any jurisdiction or institution, but rather to determine whether ISHLT has sufficient confidence that a scientific submission is consistent with the Society's ethical principles to warrant presentation under the ISHLT name.
Read at JHLTRelated Guidlines
-
ISHLT Working Formulation of a Standardized Nomenclature for Cardiac Allograft Vasculopathy—2010
-
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
-
Donor Heart and Lung Procurement: A Consensus Statement
-
ISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation
-
Consensus Statements from the ISHLT Consensus Conference: Heart Failure Related Cardiogenic Shock

